Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cholecystitis

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...

Pulmonary Embolism I: Introduction

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...

Pulmonary Embolism I: Introduction

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...

Venous Thrombosis I: Introduction

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The landscape of serum autoantibodies in lupus nephritis.

Autoimmunity reviews·2026

Same author

Sodium-Glucose Cotransporter-2-inhibitors in Adult Patients With Alport Syndrome.

Kidney international reports·2026

Same author

Natural History and Clinical Associations with Long-Term Outcomes in Primary C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative GN.

Clinical journal of the American Society of Nephrology : CJASN·2025

Same author

Tolvaptan in Autosomal Dominant Polycystic Kidney Disease (ADPKD): a multicenter real life Italian experience.

Clinical kidney journal·2025

Same author

Author Correction: Exome analysis links kidney malformations to developmental disorders and reveals causal genes.

Nature communications·2025

Same author

Exome analysis links kidney malformations to developmental disorders and reveals causal genes.

Nature communications·2025

Search research articles

Related Experiment Video

Updated: May 28, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Cholesterol crystal embolism (atheroembolism).

Chiara Venturelli¹, Guido Jeannin, Laura Sottini

¹Scuola di Specializzazione in Nefrologia Clinica, Università degli Studi di Brescia, Brescia - Italy.

Heart International

|October 7, 2011

Summary

Cholesterol crystal embolism, or atheroembolic disease, occurs when plaque fragments block arteries, potentially causing kidney damage. Early diagnosis and intervention are crucial for better outcomes in this condition.

Keywords:

Atherosclerosis Cholesterol crystals Renal atheroembolic disease

More Related Videos

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

Published on: January 7, 2019

Cholesterol Efflux Assay

Cholesterol Efflux Assay

Published on: March 6, 2012

Related Experiment Videos

Last Updated: May 28, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

Published on: January 7, 2019

Cholesterol Efflux Assay

Cholesterol Efflux Assay

Published on: March 6, 2012

Area of Science:

Cardiovascular Medicine
Nephrology
Pathology

Background:

Cholesterol crystal embolism (atheroembolic disease) results from atherosclerotic plaque fragmentation.
Embolization can be spontaneous or iatrogenic, often following vascular procedures or anticoagulation.
This condition can lead to varying degrees of renal impairment, from moderate dysfunction to severe failure requiring dialysis.

Purpose of the Study:

To review the clinical presentation, diagnosis, and management of atheroembolic renal disease.
To highlight the importance of recognizing this condition for potentially improving patient outcomes.

Main Methods:

Review of clinical literature and case presentations related to atheroembolic disease.
Analysis of diagnostic challenges and therapeutic approaches.

Main Results:

Atheroembolism can affect multiple organs, including kidneys, skin, gastrointestinal, and central nervous systems.
Diagnosis is challenging due to varied manifestations, with a classic triad suggesting the condition.
Biopsy confirmation is often required, and while specific treatment is lacking, aggressive management may improve outcomes.

Conclusions:

Increased awareness and clinical vigilance are essential for diagnosing atheroembolic renal disease.
Prompt diagnosis and management are critical, as aggressive therapeutic approaches may lead to more favorable clinical outcomes.